Study limitation
This study does have some limitations that must be addressed in future studies. These include a small number of patients, a short treatment and follow-up period, and the lack of analysis of immune-inflammatory factors. These limitations will be addressed in future multicenter studies of Canocapavir in more patients with a more extended treatment and follow-up period.